Genetic Acute Necrotizing Encephalopathy Associated with RANBP2: Clinical and Therapeutic Implications in Pediatrics

Jesse M Levine, Nusrat Ahsan, Eugenia Ho, Jonathan D Santoro, Jesse M Levine, Nusrat Ahsan, Eugenia Ho, Jonathan D Santoro

Abstract

Genetic (also known as familial) acute necrotizing encephalopathy (ANE1) is a rare disease presenting with encephalopathy often following preceding viral febrile illness in patients with a genetic predisposition resulting from a missense mutation in the gene encoding RAN Binding Protein 2 (RANBP2). The acute episode is characterized by deterioration in consciousness, often with focal neurologic deficits and seizures. Additionally, symmetric multifocal brain lesions are seen in the bilateral thalami as well as other characteristic regions, involving both gray and white matter. Prognosis is variable, with a high mortality rate and most surviving patients having persistent neurologic deficits. Early treatment with high dose steroids is associated with a more favorable outcome, however the diagnosis is often overlooked resulting in delayed treatment. The RANBP2 mutation associated with ANE1 causes an incompletely penetrant predisposition to encephalopathy in the setting of febrile illness through a mechanism that remains elusive. There are several non-mutually exclusive hypotheses suggesting possible etiologies for this phenotype based on the many functions of RANBP2 within the cell. These include dysfunctions in nucleocytoplasmic trafficking and intracellular metabolic regulation, as well as cytokine storm, and abnormal distribution of mitochondria. This narrative review explores these key concepts of the RANBP2 mutation and its clinical and therapeutic implications in pediatric populations.

Keywords: Acute necrotizing encephalopathy; Encephalopathy; Genetic; RANBP2; Thalami.

Conflict of interest statement

Declaration of competing interest The authors declare no competing interests.

Copyright © 2020 Elsevier B.V. All rights reserved.

Figures

Figure 1
Figure 1
A) 12-year-old female with a diagnosis of ANE1. Axial FLAIR demonstrating bi-thalamic involvement and left temporal lobe edema. B) Same 12-year-old female with ANE1. Sagital T2 demonstrating thalamic and brainstem hypertintensities with sparing of the cortical structures
Figure 2
Figure 2
Dynamic changes of magnetic resonance imaging (MRI) of a patient with acute necrotizing encephalopathy (ANE). (a) was computerized tomography (CT) at onset; (b) and (c), (d) and (e), and (f) and (g) were, respectively, the T1-weighted image (T1WI), T2WI, and fluid attenuated inversion recovery (FLAIR) image at onset which showed lesions on bilateral thalamus and brain stem (blue arrow); (h) and (i), (g) and (k), and (l) were, respectively, the T1WI, T2WI, and FLAIR imaging of follow-up which revealed disappearance of the brain stem lesions and impressive regression of the thalamic lesions, just left hemosiderin deposition (red arrow). Displayed with permission from Wu et al., 2015.
Figure 3
Figure 3
Diffusion findings in acute-stage ANE in a 2-year-old girl. A, Diffusion-weighted MR images (b = 1000) show bilateral symmetric diffuse hyperintense lesions in the cerebellar-cerebral white matter, thalami, and pontine tegmenta. B, The ADC map shows three different patterns of the thalamus and cerebral white matter. The center of the lesions shows higher ADC values than those of normal parenchyma, the peripheral portion of central lesions shows very low ADC values, and outside the thalamus and cerebral white matter are high ADC values, findings compatible with vasogenic edema. Note that the splenium of corpus callosum, pontine tegmanta, optic radiatia, and cerebellar white matter have low ADC values in the central portion and high ADC values in the peripheral portion. C, Mean ADC values and pattern on the right thalamus (A, center of thalamic lesions; B, periphery of the central thalamic lesions; C, outside portions of the thalamic lesions). Displayed with permission from Albayram et al., 2004.
Figure 4
Figure 4
Roles of RANBP2 and effects of RANBP2 disruption

References

    1. Aiba H, Mochizuki M, Kimura M, Hojo H. Predictive value of serum interleukin-6 level in influenza virus-associated encephalopathy. Neurology. 2001;57:295–299.
    1. Akiyoshi K, Hamada Y, Yamada H, Kojo M, Izumi T. Acute necrotizing encephalopathy associated with hemophagocytic syndrome. Pediatr Neurol. 2006;34:315–318.
    1. Albayram S, Bilgi Z, Selcuk H. Diffusion-weighted MR imaging findings of acute necrotizing encephalopathy. AJNR Am J Neuroradiol. 2004;25:792–797.
    1. Alsolami A, Shiley K. Successful treatment of influenza-associated acute necrotizing encephalitis in an adult using high-dose oseltamivir and methylprednisolone: case report and literature review. Open Forum Infect Dis. 2017;4(3) ofx145.
    1. Anand G, Visagan R, Chandratre S, Segal S, Nemeth AH, Squier W, Sheerin F. H1N1 triggered recurrent acute necrotizing encephalopathy in a family with a T653I utation in the RANBP2 gene. Pediatr Infect Dis J. 2015;34:318–320.
    1. Ashtekar CS, Jaspan T, Thomas D, Weston V, Gayatri NA, Whitehouse WP. Acute bilateral thalamic necrosis in a child with Mycoplasma pneumoniae. Dev Med Child Neurol. 2003;45:634–637.
    1. Aslanukov A, Bhowmick R, Guruju M, Oswald J, Raz D, Bush RA. RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficits in glucose metabolism. PLoS Genet. 2006;2:e177.
    1. Aydin H, Ozgul E, Agildere AM. Acute necrotizing encephalopathy secondary to diphtheria, tetanus toxoid and whole-cell pertussis vaccination: diffusion-weighted imaging and proton MR spectroscopy findings. Pediatr Radiol. 2010;40:1281–1284.
    1. Baumann M, Sahin K, Lechner C, Hennes EM, Schanda K, Mader S. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. J Neurol Neurosurg Psychiatry. 2015;86:265–272.
    1. Bloch C, Suter B, Fischmann A, Gensicke H, Ruegg S, Weisser M. Only a Touch of the Flu? The Simultaneous Manifestation of Acute Necrotizing Encephalopathy in Two Consanguineous Patients. Open Forum Infect Dis. 2015;2 ofv013.
    1. Britton PN, Blyth CC, Macartney K, Dale RC, Li-Kim-Moy J, Khandaker G. The Spectrum and Burden of Influenza-Associated Neurological Disease in Children: Combined Encephalitis and Influenza Sentinel Site Surveillance From Australia, 2013-2015. Clin Infect Dis. 2017;65(4):653–660.
    1. Carmo RLD, Alves Simao AK, Amaral LLFD, Inada BSY, Silveira CF, Campos CMS. Neuroimaging of emergent and reemergent infections. Radiographics. 2019;39(6):1649–1671.
    1. Cho KI, Searle K, Webb M, Yi H, Ferreira PA. Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Cell Mol Life Sci. 2012;69:3511–3527.
    1. Cho KI, Yi H, Tserentsoodol N, Searle K, Ferreira PA. Neuroprotection resulting from insufficiency of RANBP2 is associated with the modulation of protein and lipid homeostasis of functionally diverse but linked pathways in response to oxidative stress. Dis Model Mech. 2010;3:595–604.
    1. Cho KI, Yoon D, Qiu S, Danziger Z, Grill WM, Wetsel WC. Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes. Dis Model Mech. 2017;10:559–579.
    1. Hosoya M, Nunoi H, Aoyama M, Kawasaki Y, Suzuki H. Cytochrome c and tumor necrosis factor-alpha values in serum and cerebrospinal fluid of patients with influenza-associated encephalopathy. Pediatr Infect Dis J. 2005;24:467–470.
    1. Howard A, Uyeki TM, Fergie J. Influenza-Associated Acute Necrotizing Encephalopathy in Siblings. J Pediatric Infect Dis Soc. 2018;7:e172–e1e7.
    1. Huang SM, Chen CC, Chiu PC, Cheng MF, Lai PH, Hsieh KS. Acute necrotizing encephalopathy of childhood associated with influenza type B virus infection in a 3-year-old girl. J Child Neurol. 2004;19:64–67.
    1. Ichiyama T, Endo S, Kaneko M, Isumi H, Matsubara T, Furukawa S. Serum cytokine concentrations of influenza-associated acute necrotizing encephalopathy. Pediatr Int. 2003;45:734–736.
    1. Ishida Y, Kawashima H, Morichi S, Yamanaka G, Okumura A, Nakagawa S. Brain magnetic resonance imaging in acute phase of pandemic influenza A (H1N1) 2009 – associated encephalopathy in children. Neuropediatrics. 2015;46(1):20–25.
    1. Isikay S, Sahin Y. RANBP2 mutation in clinically undiagnosed acute necrotizing encephalopathy. Indian J Pediatr. 2019;85:820–821. 8.
    1. Kelly E, Harvey J, Brion K, Fletcher J, Slee M. Relapsing necrotising encephalomyelopathy due to RANBP2 mutation. Pract Neurol. 2019;19:360–363.
    1. Khandaker G, Zurynski Y, Buttery J, Marshall H, Richmond PC, Dale RC. Neurologic complications of influenza A(H1N1)pdm09: surveillance in 6 pediatric hospitals. Neurology. 2012;79(14):1474–1481.
    1. Koh JC, Murugasa A, Krishnappa J, Thomas T. Favorable outcomes with early interleukin 6 receptor blockade in severe acute necrotizing encephalopathy of childhood. Pediatr Neurol. 2019;98:80–84.
    1. Kumakura A, Iida C, Saito M, Mizuguchi M, Hata D. Pandemic influenza A-associated acute necrotizing encephalopathy without neurologic sequelae. Pediatr Neurol. 2011;45:344–346.
    1. Lee YJ, Hwang SK, Kwon S. Acute Necrotizing Encephalopathy in Children: a Long Way to Go. J Korean Med Sci. 2019;34:e143.
    1. Lyon JB, Remigio C, Milligan T, Deline C. Acute necrotizing encephalopathy in a child with H1N1 influenza infection. Pediatr Radiol. 2010;40:200–205.
    1. Marco EJ, Anderson JE, Neilson DE, Strober JB. Acute necrotizing encephalopathy in 3 brothers. Pediatrics. 2010;125:e693–e698.
    1. Mariotti P, Iorio R, Frisullo G, Plantone D, Colantonio R, Tartaglione T. Acute necrotizing encephalopathy during novel influenza A (H1N1) virus infection. Ann Neurol. 2010;68:111–114.
    1. Martin A, Reade EP. Acute necrotizing encephalopathy progressing to brain death in a pediatric patient with novel influenza A (H1N1) infection. Clin Infect Dis. 2010;50(8):e50–e52.
    1. Mastroyianni SD, Voudris KA, Katsarou E, Gionnis D, Mavromatis P, Vagiakou EA. Acute necrotizing encephalopathy associated with parainfluenza virus in a Caucasian child. J Child Neurol. 2003;18:570–572.
    1. McSwiney P, Purnama J, Kornberg A, Danchin M. A severe neurological complication of influenza in a previously well child. BMJ Case Rep. 2014;2014 bcr2014206930.
    1. Mizuguchi M, Abe J, Mikkaichi K, Noma S, Yoshida K, Yamanaka T. Acute necrotising encephalopathy of childhood: a new syndrome presenting with multifocal, symmetric brain lesions. J Neurol Neurosurg Psychiatry. 1995;58:555–561.
    1. Mizuguchi M, Yamanouchi H, Ichiyama T, Shiomi M. Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand. 2007;115(Suppl. 186):45–56.
    1. Narita M. Acute necrotizing encephalopathy by Mycoplasma pneumoniae infection? Arch Intern Med. 2002;162:1647.
    1. Neilson D. Susceptibility to Infection-Induced Acute Encephalopathy 3. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, editors. GeneReviews(R) SeattleWA; 2014.
    1. Neilson DE, Adams MD, Orr CM, Schelling DK, Eiben RM, Kerr DS. Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2. Am J Hum Genet. 2009;84:44–51.
    1. Neilson DE, Eiben RM, Waniewski S, Hoppel CL, Varnes ME, Bangert BA. Autosomal dominant acute necrotizing encephalopathy. Neurology. 2003;61:226–230.
    1. Neilson DE. The interplay of infection and genetics in acute necrotizing encephalopathy. Curr Opin Pediatr. 2010;22:751–757.
    1. Nishimura N, Higuchi Y, Kimura N, Nozaki F, Kumada T, Hoshino A. Familial acute necrotizing encephalopathy without RANBP2 mutation: poor outcome. Pediatr Int. 2016;58:1215–1218.
    1. Ohsaka M, Houkin K, Takigami M, Koyanagi I. Acute necrotizing encephalopathy associated with human herpesvirus-6 infection. Pediatr Neurol. 2006;34(2):160–163.
    1. Oki J, Yoshida H, Tokumitsu A, Takahashi S, Miyamoto A, Yoda M. Serial neuroimages of acute necrotizing encephalopathy associated with human herpesvirus 6 infection. Brain Dev. 1995;17:356–359.
    1. Okumura A, Mizuguchi M, Aiba H, Tanabe T, Tsuji T, Ohno A. Delirious behavior in children with acute necrotizing encephalopathy. Brain Dev. 2009;31:594–599.
    1. Okumura A, Mizuguchi M, Kidokoro H, Tanaka M, Abe S, Hosoya M. Outcome of acute necrotizing encephalopathy in relation to treatment with corticosteroids and gammaglobulin. Brain Dev. 2009;31:221–227.
    1. Ormitti F, Ventura E, Summa A, Picetti E, Crisi G. Acute necrotizing encephalopathy in a child during the 2009 influenza A(H1N1) pandemia: MR imaging in diagnosis and follow-up. AJNR Am J Neuroradiol. 2010;31:396–400.
    1. Patil H, Cho KI, Lee J, Yang Y, Orry A, Ferreira PA. Kinesin-1 and mitochondrial motility control by discrimination of structurally equivalent but distinct subdomains in Ran-GTP-binding domains of Ran-binding protein 2. Open Biol. 2013;3
    1. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. 2020 [Epub ahead of print]
    1. San Millan B, Teijeira S, Penin C, Garcia JL, Navarro C. Acute necrotizing encephalopathy of childhood: report of a Spanish case. Pediatr Neurol. 2007;37:438–441.
    1. Sazgar M, Robinson JL, Chan AK, Sinclair DB. Influenza B acute necrotizing encephalopathy: a case report and literature review. Pediatr Neurol. 2003;28:396–399.
    1. Sell K, Storch K, Hahn G, Lee-Kirsch MA, Ramantani G, Jackson S. Variable clinical course in acute necrotizing encephalopathy and identification of a novel RANBP2 mutation. Brain Dev. 2016;38:777–780.
    1. Seo HE, Hwang SK, Choe BH, Cho MH, Park SP, Kwon S. Clinical spectrum and prognostic factors of acute necrotizing encephalopathy in children. J Korean Med Sci. 2010;25:449–453.
    1. Singh RR, Sedani S, Lim M, Wassmer E, Absoud M. RANBP2 mutation and acute necrotizing encephalopathy: 2 cases and a literature review of the expanding clinico-radiological phenotype. Eur J Paediatr Neurol. 2015;19:106–113.
    1. Skelton BW, Hollingshead MC, Sledd AT, Phillips CD, Castillo M. Acute necrotizing encephalopathy of childhood: typical findings in an atypical disease. Pediatr Radiol. 2008;38:810–813.
    1. Sondhi V, Chakrabarty B, Kumar A, Kohli S, Saxena R, Verma IC. RANBP2 mutation in an Indian child with recurrent acute necrotizing encephalopathy. Brain Dev. 2016;38:937–942.
    1. Soriano-Ramos M, Navarro-Abia V, Enamorado NN, Camacho-Salas A, De Aragon AM, Garcia-Hoyos M. Steroids for familial acute necrotizing encephalopathy: A future investment? Clin Neurol Neurosurg. 2018;174:134–136.
    1. Sugaya N. Influenza-associated encephalopathy in Japan. Semin Pediatr Infect Dis. 2002;13:79–84.
    1. Tran TD, Kubota M, Takeshita K, Yanagisawa M, Sakakihara Y. Varicella-associated acute necrotizing encephalopathy with a good prognosis. Brain Dev. 2001;23:54–57.
    1. Wu X, Wu W, Pan W, Wu L, Liu K, Zhang HL. Acute necrotizing encephalopathy: an underrecognized clinicoradiologic disorder. Mediators Inflamm. 2015;2015
    1. Yoshikawa H, Watanabe T, Abe T, Oda Y. Clinical diversity in acute necrotizing encephalopathy. J Child Neurol. 1999;14:249–255.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe